Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 4Venous Thrombosis 2Venous Thromboembolism 2Pulmonary Embolism 2Thrombosis 1Small Cell Lung Carcinoma 1Hemorrhage 1Carcinoma, Small Cell 1

Interventions

Tranexamic Acid 13Sodium Chloride 4Misoprostol 4Saline Solution 3Enoxaparin 3carbetocin 2Tourniquets 2Ringer's Lactate 2Oxytocin 2Endoscopic Mucosal Resection 2Dalteparin 2Aspirin 2maleimide-polyethylene glycol-modified hemoglobin, MP4 1bemiparin 1Vitamin B 6 1Vasopressins 1Uterine Myomectomy 1Uterine Artery Embolization 1Ultrasonography 1Tinzaparin 1Thoracic Surgery, Video-Assisted 1Terlipressin 1Sutures 1Surveys and Questionnaires 1Surgicel 1Standard of Care 1Solutions 1Sensitivity Training Groups 1Rivaroxaban 1Ringer's Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemorrhage × bemiparin × Clear all
NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Rovi Pharmaceuticals Laboratories

Phase 3 Completed
526 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡